Depression: epigenetics and epitranscriptomic modifications

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Major Depressive Disorder (MDD) affects millions globally, with complex origins.
• MDD development involves genetic vulnerability and environmental factors like early-life stress.
• Current research increasingly focuses on molecular mechanisms beyond genetics.

Purpose of the Study:

• To investigate the interconnection between epigenetic alterations, epitranscriptomic modifications, and MDD.
• To identify potential therapeutic interventions for depression by understanding DNA and RNA regulation.
• To provide a detailed molecular understanding of MDD.

Main Methods:

• Comprehensive literature review of recent studies on MDD, epigenetics, and epitranscriptomics.
• Analysis of existing research focusing on chromatin-level and RNA-level regulatory changes.
• Synthesis of findings to highlight associations and potential therapeutic targets.

Main Results:

• A significant association exists between chromatin modifications and RNA regulatory changes in MDD.
• MDD arises from a combination of genetic predispositions and environmental influences.
• Research is expanding to include posttranscriptional RNA modifications alongside DNA epigenetic changes in depression studies.

Conclusions:

• Understanding epigenetic and epitranscriptomic changes offers new insights into MDD's molecular underpinnings.
• Chromatin-RNA regulators and pathways represent promising targets for novel MDD therapeutics.
• This review aids in developing more effective treatments for Major Depressive Disorder.